13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001325083
Total reported value
$214.3M
$214.3M
37 檔
31.9%
In Q1 2026, Knoll Capital Management, LLC's U.S. equity holdings reached a combined market value of $214.3M, distributed across 37 disclosed stock positions.
In Q1 2026, Knoll Capital Management, LLC displayed an active expansion posture, initiating 8 new positions and adding to 3 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BHVN | Biohaven Ltd. | Stock-Other | 10.93% | +5.40% | — | |
| 2 | PHYS | Sprott Physical Gold Trust | Stock-Other | 7.61% | -2.16% | — | |
| 3 | RGLD | Royal Gold Inc | Stock-Materials | 7.45% | -2.54% | — | |
| 4 | MGTX | MeiraGTx Holdings plc | Stock-Other | 6.01% | +1.87% | — | |
| 5 | AEM | Agnico Eagle Mines LTD | Stock-Materials | 5.94% | -2.12% | — | |
| 6 | KGC | Kinross Gold CORP | Stock-Materials | 5.42% | -1.89% | -21.95% | |
| 7 | ALDX | Aldeyra Therapeutics Inc | Stock-Other | 5.14% | +0.30% | — | |
| 8 | SEA1EUR | Seabridge Gold Inc | Stock-Other | 4.99% | -1.18% | — | |
| 9 | FNV | Franco-nevada CORP | Stock-Materials | 4.39% | -1.28% | +28.00% | |
| 10 | SSRM | Ssr Mining Inc | Stock-Materials | 4.00% | -0.77% | — | |
| 11 | ELTX | Elicio Therapeutics Inc | Stock-Other | 3.74% | -1.53% | — | |
| 12 | ✓ | Entera Bio LTD | Stock-Other | 3.59% | +1.27% | — | |
| 13 | NUVB | Nuvation Bio Inc | Stock-Other | 3.57% | +0.67% | — | |
| 14 | CGAU | Centerra Gold Inc | Stock-Other | 3.54% | -0.88% | -27.82% | |
| 15 | PAAS | Pan American Silver CORP | Stock-Materials | 3.03% | -0.94% | — | |
| 16 | PSLV | Sprott Physical Silver Trust | Stock-Other | 3.01% | -1.05% | — | |
| 17 | OCUL | Ocular Therapeutix Inc | Stock-Other | 2.82% | +2.45% | — | |
| 18 | TFPM | Triple Flag Precious Met | Stock-Materials | 2.22% | -0.61% | +95.58% | |
| 19 | GROY | Gold Royalty CORP | Stock-Other | 1.99% | -0.70% | — | |
| 20 | AGI | Alamos Gold Inc-class A | Stock-Materials | 1.23% | -0.52% | — | |
| 21 | ABEO | Abeona Therapeutics Inc | Stock-Other | 1.21% | +0.19% | +105.77% | |
| 22 | NEWP | New Pacific Metals CORP | Stock-Other | 1.11% | -0.20% | — | |
| 23 | CDE | Coeur Mining Inc | Stock-Materials | 1.00% | -0.27% | — | |
| 24 | ITA | Ishares U.s. Aerospace & Def | ETF-Other | 0.93% | -0.06% | — | |
| 25 | PM | Philip Morris International | Stock-Consumer Staples | 0.92% | -0.08% | — | |
| 26 | WPM | Wheaton Precious Metals CORP | Stock-Materials | 0.91% | -0.25% | — | |
| 27 | NOC | Northrop Grumman CORP | Stock-Industrials | 0.82% | -0.31% | — | |
| 28 | BAH | Booz Allen Hamilton Holdings | Stock-Industrials | 0.56% | +2.10% | — | |
| 29 | ELE | Elemental Royalty CORP | Stock-Other | 0.52% | -0.11% | — | |
| 30 | VMET | Versamet Royalties CORP | Stock-Other | 0.35% | +0.03% | — | |
| 31 | DC | Dakota Gold CORP | Stock-Other | 0.34% | -0.10% | — | |
| 32 | AMRZ | Amrize Ltd | Stock-Materials | 0.29% | -0.06% | — | |
| 33 | ALT | Altimmune Inc | Stock-Other | 0.27% | -0.04% | -85.73% | |
| 34 | CRDL | Cardiol Therapeutics Inc-a | Stock-Other | 0.07% | -0.07% | EXIT | |
| 35 | PHAR | Pharming Group NV - Adr | Stock-Other | 0.04% | -0.01% | — | |
| 36 | ✓ | Orgenesis, Inc. | Stock-Other | 0.02% | -0.01% | — | |
| 37 | OR | Or Royalties Inc | Stock-Other | — | +3.32% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RGLD | Royal Gold Inc | +2.1% | — | Unchanged |
| 2 | FNV | Franco-nevada CORP | +2% | +28.00% | Add |
| 3 | AEM | Agnico Eagle Mines LTD | +1.8% | — | Unchanged |
| 4 | SSRM | Ssr Mining Inc | +1.5% | — | Unchanged |
| 5 | MGTX | MeiraGTx Holdings plc | +1.5% | — | Unchanged |
| 6 | ELTX | Elicio Therapeutics Inc | +1.4% | — | Unchanged |
| 7 | TFPM | Triple Flag Precious Met | +1.3% | +95.58% | Add |
| 8 | SEA1EUR | Seabridge Gold Inc | +0.7% | — | Unchanged |
| 9 | PAAS | Pan American Silver CORP | +0.7% | — | Unchanged |
| 10 | ABEO | Abeona Therapeutics Inc | +0.6% | +105.77% | Add |
| 11 | AGI | Alamos Gold Inc-class A | +0.4% | — | Unchanged |
| 12 | NEWP | New Pacific Metals CORP | +0.3% | — | Unchanged |
| 13 | CGAU | Centerra Gold Inc | +0.3% | -27.82% | Trim |
| 14 | NOC | Northrop Grumman CORP | +0.3% | — | Unchanged |
| 15 | WPM | Wheaton Precious Metals CORP | +0.2% | — | Unchanged |
| 16 | CDE | Coeur Mining Inc | +0.2% | — | Unchanged |
| 17 | PM | Philip Morris International | +0.2% | — | Unchanged |
| 18 | ITA | Ishares U.s. Aerospace & Def | +0.2% | — | Unchanged |
| 19 | KGC | Kinross Gold CORP | +0.1% | -21.95% | Trim |
| 20 | BAH | Booz Allen Hamilton Holdings | +0.1% | — | Unchanged |
| 21 | CRDL | Cardiol Therapeutics Inc-a | 0% | — | Unchanged |
| 22 | DC | Dakota Gold CORP | 0% | — | Unchanged |
| 23 | ✓ | Orgenesis, Inc. | 0% | — | Unchanged |
| 24 | OCUL | Ocular Therapeutix Inc | -0.5% | — | Unchanged |
| 25 | BHVN | Biohaven Ltd. | -1.1% | — | Unchanged |
| 26 | ALT | Altimmune Inc | -1.6% | -85.73% | Trim |
| 27 | ✓ | Entera Bio LTD | -1.6% | — | Unchanged |
| 28 | NUVB | Nuvation Bio Inc | -2.6% | — | Unchanged |
| 29 | ALDX | Aldeyra Therapeutics Inc | -7.9% | — | Unchanged |
| 30 | PHYS | Sprott Physical Gold Trust | — | NEW | New buy |
| 31 | ✓ | Avadel Pharmaceuticals PLC ADR | — | EXIT | Sold out |
| 32 | GLD | Spdr Gold Shares | — | EXIT | Sold out |
| 33 | PSLV | Sprott Physical Silver Trust | — | NEW | New buy |
| 34 | SLV | Ishares Silver Trust | — | EXIT | Sold out |
| 35 | GROY | Gold Royalty CORP | — | NEW | New buy |
| 36 | ELE | Elemental Royalty CORP | — | NEW | New buy |
| 37 | VMET | Versamet Royalties CORP | — | NEW | New buy |
| 38 | APLT | Applied Therapeutics Inc | — | EXIT | Sold out |
| 39 | AMRZ | Amrize Ltd | — | NEW | New buy |
| 40 | PHAR | Pharming Group NV - Adr | — | NEW | New buy |
| 41 | OR | Or Royalties Inc | — | NEW | New buy |
According to official SEC Form 13F filings, Knoll Capital Management, LLC reported a total U.S. public equity portfolio value of $214.3M across 37 disclosed positions in Q1 2026.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including BHVN, PHYS, RGLD) accounted for 31.9% of total reported equity market value during Q1 2026.
Top New Position Initiated
PHYS
市值: $13.7M
Top Position Liquidated / Trimmed
Avadel Pharmaceuticals PLC ADR
前期市值: $12.9M
During Q1 2026, Knoll Capital Management, LLC's top holdings by market value included BHVN (10.9%)、PHYS (7.6%)、RGLD (7.5%). The largest single position, BHVN, represented 10.9% of total portfolio value.
In Q1 2026, Knoll Capital Management, LLC made 18 total portfolio adjustments, initiating 8 new buys, adding to 3 positions, trimming 3 holdings, and fully liquidating 4 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.